Latest Insights

COVID-19 Revenue Cycle Performance Metrics
One Minute with Me. Hospital and health system revenue cycle performance metrics look good in April - e.g. debit A/R is down 16.1% nationally. Is it real? No.

South Florida Hospitals Trying to Lure Patients Back
Although many Florida hospitals reopened for non-emergency medical procedures on Monday, they found themselves in an unanticipated position: convincing patients to return. After six weeks of hearing that hospitals are ground zero for the COVID-19 crisis, some South Floridians say they are too afraid of catching the virus to go to one.

Beyond the COVID-19 Surge
One Minute with Me. My thoughts on how hospitals can prepare to move beyond COVID-19, successfully.

CARES Act No Match for Drastic Decline in Outpatient Net Revenue
The Coronavirus Aid, Relief, and Economic Security Act (CARES Act) is aimed at providing relief for individuals and businesses that have been negatively affected by the coronavirus pandemic. The legislation contains many aspects and recipient categories, with healthcare being a major beneficiary.

‘C’mon back,’ says Baylor Scott & White in a Bid to Attract Patients and Boost Revenue
“Increases in patient volume from COVID-19 cases appear to have been dramatically offset by declines in other parts of the business, said Brian Sanderson, managing principal of health care services at Crowe. And federal relief packages, such as the $100 million sent to Baylor last month, won’t cover the gap…”

Hospital Volumes Hit Unprecedented Lows
Hospital volumes have dropped so dramatically and quickly since the end of February that many health system financial executives are scrambling for sources of cash.

Excluding NYC AND SF, Hospitals losing $1.4B In Revenue Per Day Due To COVID-19 Pandemic
Outside of New York City and San Francisco, hospitals across the country are losing approximately $1.4 billion in net revenue per day due to the ongoing coronavirus disease 2019 (COVID-19) outbreak, according to a Crowe LLP report released Friday morning.